We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+17.22%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$270M
AUM Growth
+$52.1M
Cap. Flow
+$22M
Cap. Flow %
8.14%
Top 10 Hldgs %
40.76%
Holding
941
New
464
Increased
200
Reduced
32
Closed
8

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.34M
2
XOM icon
ExxonMobil
XOM
+$1.31M
3
CVX icon
Chevron
CVX
+$1.25M
4
LLY icon
Eli Lilly
LLY
+$685K
5
JPM icon
JPMorgan Chase
JPM
+$684K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.18M
2
NVDA icon
NVIDIA
NVDA
+$618K
3
AVGO icon
Broadcom
AVGO
+$138K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$113K
5
AAPL icon
Apple
AAPL
+$105K

Sector Composition

Rank Sector Weight
1 Technology 44.15%
2 Healthcare 9.98%
3 Consumer Staples 7.57%
4 Financials 6.32%
5 Industrials 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBHC icon
801
National Bank Holdings
NBHC
$1.94B
$1.05K ﹤0.01%
+29
New +$1.01K
ARKW icon
802
ARK Web x.0 ETF
ARKW
$1.64B
$1K ﹤0.01%
12
SNV
803
DELISTED
Synovus
SNV
$971 ﹤0.01%
+24
New +$902
NEOG icon
804
Neogen
NEOG
$2.05B
$947 ﹤0.01%
+60
New +$1K
STWD icon
805
Starwood Property Trust
STWD
$6.12B
$936 ﹤0.01%
+45
New +$911
NEWT icon
806
NewtekOne
NEWT
$417M
$897 ﹤0.01%
80
UCB
807
United Community Banks
UCB
$4.22B
$876 ﹤0.01%
+33
New +$891
IONS icon
808
Ionis Pharmaceuticals
IONS
$9.35B
$867 ﹤0.01%
20
CPF icon
809
Central Pacific Financial
CPF
$1.01B
$830 ﹤0.01%
+42
New +$803
OHI icon
810
Omega Healthcare
OHI
$15.4B
$823 ﹤0.01%
+26
New +$790
CMPR icon
811
Cimpress
CMPR
$2.37B
$797 ﹤0.01%
+9
New +$764
MTUM icon
812
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
$749 ﹤0.01%
4
FIBK icon
813
First Interstate BancSystem
FIBK
$3.7B
$544 ﹤0.01%
+20
New +$546
HSBC icon
814
HSBC
HSBC
$355B
$532 ﹤0.01%
+13
New +$507
PSCU icon
815
Invesco S&P SmallCap Utilities & Communication Services ETF
PSCU
$17.2M
$515 ﹤0.01%
10
TDC icon
816
Teradata
TDC
$2.68B
$464 ﹤0.01%
12
BBT
817
Beacon Financial Corp
BBT
$2.53B
$462 ﹤0.01%
+20
New +$458
XRX icon
818
Xerox
XRX
$337M
$454 ﹤0.01%
25
BCS icon
819
Barclays
BCS
$94.1B
$428 ﹤0.01%
+44
New +$360
MLKN icon
820
MillerKnoll
MLKN
$1.5B
$399 ﹤0.01%
+16
New +$450
SAFE
821
Safehold
SAFE
$1.19B
$374 ﹤0.01%
+18
New +$374
POCI icon
822
Precision Optics
POCI
$47.1M
$366 ﹤0.01%
66
REZI icon
823
Resideo Technologies
REZI
$5.23B
$359 ﹤0.01%
+16
New +$316
IIPR icon
824
Innovative Industrial Properties
IIPR
$1.78B
$316 ﹤0.01%
3
OGN icon
825
Organon & Co
OGN
$3.55B
$248 ﹤0.01%
13
+10
+333% +$172

Similar funds

Front Row Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Front Row Advisors held 941 positions worth $270M, up 24% from $218M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Front Row Advisors deployed $22M of net new capital in Q1 2024, opening 464 new positions and adding to 200 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 8,008 shares worth $525K.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Pfizer, an estimated $1.18M trimmed.

  • Front Row Advisors's largest Q1 2024 buy was Vanguard Information Technology ETF: 8,008 shares worth $525K.
  • Front Row Advisors added most to Berkshire Hathaway Class B in Q1 2024, an estimated $1.34M increase.
  • Front Row Advisors's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.18M.
  • Front Row Advisors fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q1 2024, selling an estimated $16.2K.
  • Front Row Advisors's ten largest holdings make up 41% of its $270M portfolio in Q1 2024.
  • Front Row Advisors opened 464 new positions and closed 8 in Q1 2024.
  • Front Row Advisors's portfolio value rose 24% quarter-over-quarter to $270M.

Based on Front Row Advisors's 13F filing for Q1 2024, filed 14 May 2024.